These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 26813985)
1. Quetiapine safety in older adults: a systematic literature review. El-Saifi N; Moyle W; Jones C; Tuffaha H J Clin Pharm Ther; 2016 Feb; 41(1):7-18. PubMed ID: 26813985 [TBL] [Abstract][Full Text] [Related]
2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480 [TBL] [Abstract][Full Text] [Related]
5. Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Stogios N; Smith E; Bowden S; Tran V; Asgariroozbehani R; McIntyre WB; Remington G; Siskind D; Agarwal SM; Hahn MK Neuropsychopharmacology; 2022 Feb; 47(3):664-672. PubMed ID: 34446830 [TBL] [Abstract][Full Text] [Related]
6. [Safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms in dementia: a meta-analysis]. Xue XJ; He RL; Li WX; Xin JW; Ye QY; Chen XC; Pan XD Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(25):2030-2036. PubMed ID: 29996606 [No Abstract] [Full Text] [Related]
7. Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study. Chyou TY; Nishtala R; Nishtala PS Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):692-700. PubMed ID: 32301237 [TBL] [Abstract][Full Text] [Related]
8. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. Layton D; Harris S; Wilton LV; Shakir SA J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184 [TBL] [Abstract][Full Text] [Related]
9. Off-label second generation antipsychotics for impulse regulation disorders: a review. Scheltema Beduin A; de Haan L Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846 [TBL] [Abstract][Full Text] [Related]
10. Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review. Yunusa I; Rashid N; Abler V; Rajagopalan K J Prev Alzheimers Dis; 2021; 8(4):520-533. PubMed ID: 34585228 [TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression. DelBello MP; Kadakia A; Heller V; Singh R; Hagi K; Nosaka T; Loebel A J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):243-254. PubMed ID: 34420839 [TBL] [Abstract][Full Text] [Related]
12. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Correll CU; Leucht S; Kane JM Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review. Thorey S; Blanchet C; Guessoum SB; Moro MR; Ludot M; Carretier E PLoS One; 2023; 18(3):e0278189. PubMed ID: 36928656 [TBL] [Abstract][Full Text] [Related]
16. Post authorization safety study comparing quetiapine to risperidone and olanzapine. Heintjes EM; Overbeek JA; Penning-van Beest FJ; Brobert G; Herings RM Hum Psychopharmacol; 2016 Jul; 31(4):304-12. PubMed ID: 27297785 [TBL] [Abstract][Full Text] [Related]
17. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis. Wilby KJ; Johnson EG; Johnson HE; Ensom MHH Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039 [TBL] [Abstract][Full Text] [Related]
18. Research encouraging off-label use of quetiapine: A systematic meta-epidemiological analysis. Grabitz P; Saksone L; Schorr SG; Schwietering J; Bittlinger M; Kimmelman J Clin Trials; 2024 Aug; 21(4):418-429. PubMed ID: 38284364 [TBL] [Abstract][Full Text] [Related]
19. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study. Chatterjee S; Chen H; Johnson ML; Aparasu RR Am J Geriatr Pharmacother; 2012 Apr; 10(2):83-94. PubMed ID: 22306198 [TBL] [Abstract][Full Text] [Related]